The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,166.00
Bid: 1,154.00
Ask: 1,158.00
Change: 8.00 (0.69%)
Spread: 4.00 (0.347%)
Open: 1,140.00
High: 1,168.00
Low: 1,140.00
Prev. Close: 1,158.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms

23 Feb 2024 15:58

Edison Investment Research Limited Edison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms 23-Feb-2024 / 15:57 GMT/BST The issuer is solely responsible for the content of this announcement.


 

London, UK, 23 Februar 2024

 

Edison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms

Georgia Capital (GCAP) reported a Q423 NAV total return (TR) of 7.7% in Georgian lari (GEL) terms (3.4% in sterling terms), bringing the FY23 NAV TR to a strong 26.5% (20.4% in sterling terms). The considerable increase in the sterling share price of Bank of Georgia (BoG) was the main contributor, adding c 5.1% and 19.5% to GCAP’s opening NAV in Q423 and FY23, respectively. This was further assisted by positive revaluation of all large and investment-stage private holdings, except for the hospital business. In aggregate, GCAP’s private holdings added 1.9pp to its Q423 NAV TR. NAV-accretive buybacks of US$8.3m added a further 0.9pp.

Despite the c 50% appreciation in GCAP’s share price over the last 12 months, its shares still trade at a c 52% discount to NAV (when adjusted for the post-balance sheet change in BoG’s share price). If GCAP’s stake in BoG (which at end-2023 made up 33% of total portfolio value) was valued in line with the last closing price, GCAP’s current market cap would imply a wide 71% discount to the end-2023 fair value of its private assets (with GCAP’s enterprise value excluding BoG roughly equal to the fair value of the retail (pharmacy) business alone).

Click here to view the full report.

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: As a content-led investor-relations business, Edison helps companies stand out and meet the right shareholders. Edison’s integrated investor relations solution combines expert analyst content, digital targeting and active investor engagement. This drives liquidity and valuations by building bigger, better informed and more engaged investor audiences globally.

Edison has a proven history of increasing liquidity and valuations for its clients. Edison’s content can be viewed by all investors, anywhere in the world.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Milosz Papst +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube http://www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1844367 23-Feb-2024 

corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
26th Apr 20233:44 pmRNSTransaction in Own Shares
25th Apr 20235:32 pmRNSTransaction in Own Shares
24th Apr 20234:21 pmRNSTransaction in Own Shares
24th Apr 20233:34 pmRNSDirector/PDMR Shareholding
20th Apr 20235:34 pmRNSTransaction in Own Shares
19th Apr 20235:33 pmRNSTransaction in Own Shares
18th Apr 20235:49 pmRNSTransaction in Own Shares
14th Apr 20232:56 pmRNSHolding(s) in Company
14th Apr 202311:51 amRNSDirector/PDMR Shareholding
13th Apr 20235:39 pmRNSTransaction in Own Shares
13th Apr 20238:00 amRNSNotice of AGM
13th Apr 20237:00 amRNSTransfer to a Standard Listing on the LSE
12th Apr 20237:00 amRNSLaunch of US$ 10 million share buyback programme
11th Apr 20235:30 pmRNSGeorgia Capital
11th Apr 202311:20 amRNSDirector/PDMR Shareholding
3rd Apr 202312:50 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSUpdate on divestments from subscale businesses
27th Mar 20235:00 pmRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSAnnual Financial Report
20th Mar 20231:16 pmRNSDirector/PDMR Shareholding
14th Mar 202312:36 pmRNSResult of Meeting
10th Mar 20233:23 pmRNSDirector/PDMR Shareholding
6th Mar 20233:32 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSEducation business continues to expand
28th Feb 20234:32 pmRNSHolding(s) in Company
27th Feb 20233:04 pmRNSDirector/PDMR Shareholding
20th Feb 20233:44 pmRNSDirector/PDMR Shareholding
20th Feb 20237:00 amRNSFinal Results
17th Feb 202310:33 amRNSNotice of GM
14th Feb 202311:00 amRNSNotice of Results
13th Feb 20234:15 pmRNSDirector/PDMR Shareholding
6th Feb 20233:37 pmRNSDirector/PDMR Shareholding
30th Jan 20235:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20235:16 pmRNSDirector/PDMR Shareholding
23rd Jan 20234:59 pmRNSDirector/PDMR Shareholding
20th Jan 20235:33 pmRNSHolding(s) in Company
19th Jan 202311:58 amRNSDirector/PDMR Shareholding
16th Jan 20235:55 pmRNSDirector/PDMR Shareholding
13th Jan 20235:04 pmRNSDirector/PDMR Shareholding
6th Jan 20235:34 pmRNSDirector/PDMR Shareholding
29th Dec 20224:29 pmRNSDirector/PDMR Shareholding
28th Dec 20229:27 amRNSDirector/PDMR Shareholding
20th Dec 202212:57 pmRNSChanges to the Board Committees
19th Dec 20221:01 pmRNSDirector/PDMR Shareholding
19th Dec 202212:58 pmRNSHolding(s) in Company
12th Dec 20221:33 pmRNSDirector/PDMR Shareholding
9th Dec 20224:13 pmRNSHolding(s) in Company
8th Dec 20224:08 pmRNSHolding(s) in Company
8th Dec 20224:05 pmRNSHolding(s) in Company
8th Dec 20224:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.